In last trading session, Bicara Therapeutics Inc (NASDAQ:BCAX) saw 0.49 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $12.62 trading at -$0.29 or -2.25% at ring of the bell on the day assigns it a market valuation of $686.73M. That closing price of BCAX’s stock is at a discount of -122.58% from its 52-week high price of $28.09 and is indicating a premium of 12.04% from its 52-week low price of $11.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.4 million shares which gives us an average trading volume of 433.09K if we extend that period to 3-months.
Bicara Therapeutics Inc (NASDAQ:BCAX) trade information
Upright in the red during last session for losing -2.25%, in the last five days BCAX remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $12.62 price level, adding 5.68% to its value on the day. Bicara Therapeutics Inc’s shares saw a change of -27.55% in year-to-date performance and have moved 8.75% in past 5-day. Bicara Therapeutics Inc (NASDAQ:BCAX) showed a performance of -25.76% in past 30-days. Number of shares sold short was 4.52 million shares which calculate 6.93 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 35 to the stock, which implies a rise of 63.94% to its current value. Analysts have been projecting 35 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -177.34% in reaching the projected high whereas dropping to the targeted low would mean a loss of -177.34% for stock’s current value.
On the other hand, Price (T.Rowe) New Horizons Fund and AB Cap Fd.-AB Small Cap Growth Port are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 589.53 shares of worth $7.44 million or 1.08% of the total outstanding shares. The later fund manager was in possession of 410.71 shares on Nov 30, 2024 , making its stake of worth around $5.18 million in the company or a holder of 0.75% of company’s stock.
